In vitro activity of telithromycin against Spanish Streptococcus pneumoniae isolates with characterized macrolide resistance mechanisms

Antimicrobial Agents and Chemotherapy

Volumn 45, Issue 9, 2001, Pages 2427-2431

  Morosini, M I ^a   Canton R ^a   Loza, E ^a   Negri, M C ^a   Galan J C ^a   Almaraz, F ^a   Baquero, F ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CEFOTAXIME; CLINDAMYCIN; DALFOPRISTIN PLUS QUINUPRISTIN; LEVOFLOXACIN; LINCOSAMIDE; MACROLIDE; MIKAMYCIN B; PENICILLIN G; SPIRAMYCIN; TELITHROMYCIN; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG SENSITIVITY; GENOTYPE; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; TREATMENT INDICATION;

ANTI-BACTERIAL AGENTS; CLINDAMYCIN; DRUG RESISTANCE, MICROBIAL; ERYTHROMYCIN; HUMANS; KETOLIDES; MACROLIDES; MICROBIAL SENSITIVITY TESTS; SPAIN; STREPTOCOCCUS PNEUMONIAE; VIRGINIAMYCIN;

EID: 0034873105     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.45.9.2427-2431.2001     Document Type: Article

References (29)

1. Antimicrobial resistance of 1,113 Streptococcus pneumoniae isolates from patients with respiratory tract infections in Spain: Results of a 1-year (1996-1997) multicenter surveillance study
2. Community-acquired pneumonia in adults: Guidelines for management
3. B resistance phenotype
4. The in-vitro activity of HMR 3647, a new ketolide antimicrobial agent
5. Kétolides
6. Molecular characterization of penicillin-resistant Streptococcus pneumoniae isolates causing respiratory disease in the United States
7. In vitro development of resistance to telithromycin (HMR 3647), four macrolides, clindamycin, and pristinamycin in Streptococcus pneumoniae
8. Macrolide resistance and erythromycin resistance determinants among Belgian Streptococcus pyogenes and Streptococcus pneumoniae isolates
9. Macrolide-ketolide inhibition of MLS-resistant ribosomes is improved by alternative drug interaction with domain II of 23S rRNA
10. The Alexander Project 1996-1997: Latest susceptibility data from this international study of bacterial pathogens from community-acquired lower respiratory tract infections
11. Evolution of Streptococcus pneumoniae serotypes and antibiotic resistance in Spain: Update (1990 to 1996)
12. Phenotypes and genotypes of erythromycin-resistant Streptococcus pyogenes strains in Italy and heterogeneity of inducibly resistant strains
13. Streptococcus pneumoniae resistance to erythromycin and penicillin in relation to macrolide and β-lactam consumption in Spain (1979-1997)
14. Comparative in-vitro activity of ketolide HMR 3647 and four macrolides against gram-positive cocci of known erythromycin susceptibility status
15. Management of community-acquired pneumonia in the era of pneumococcal resistance: A report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group
16. In vitro activities of two ketolides, HMR 3647 and HMR 3004, against gram-positive bacteria
17. Macrolide resistance mechanisms and expression of phenotypes among Streptococcus pneumoniae circulating in Italy
18. Performance standards for antimicrobial disk susceptibility tests, 6th ed. Approved standard M2-A7
19. Distribution of mefE and ermB genes in macrolide-resistant strains of Streptococcus pneumoniae and their variable susceptibility to various antibiotics
20. Susceptibility of penicillin- and erythromycin-susceptible and -resistant pneumococci to HMR 3647 (RU 66647), a new ketolide, compared with susceptibilities to 17 other agents
21. In vitro activities of the new ketolide antibiotics HMR 3004 and HMR 3647 against Streptococcus pneumoniae in Germany
22. Nomenclature for macrolide and macrolide-lincosamidestreptogramin B resistance determinants
23. Inducible or constitutive expression of resistance in clinical isolates of streptococci and enterococci cross-resistant to erythromycin and lincomycin
24. Prevalence of macrolide resistance mechanisms in Streptococcus pneumoniae isolates from a multicenter antibiotic resistance surveillance study conducted in the United States in 1994-1995
25. Antibiogram Committee of the French Microbiology Society. Report 2000-2001
26. Detection of eythromycin-resistant determinants by PCR
27. Mutations in 23S rRNA and ribosomal protein L4 account for resistance in pneumococcal strains selected in vitro by macrolide passage
28. Two new mechanisms of macrolide resistance in clinical strains of Streptococcus pneumoniae from Eastern Europe and North America